SCHEMBL7811740

SCHEMBL7811740

CC(=O)OCc1ccc(-c2nc3c(s2)C(=O)c2ccccc2C3=O)o1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 7/20 0.45
▸ TDO2 P48775 5/20 0.45
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ BCL2 P10415 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PDE7A Q13946 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7812948 0.82 IDO1 (0.52) IDO1TDO2CYP1A2CYP2C19ALDH1A1
SCHEMBL7805846 0.78 IDO1 (0.48) IDO1TDO2CYP1A2CYP2C19ALDH1A1
SCHEMBL7811891 0.77 IDO1 (0.55) IDO1TDO2CYP1A2CYP2C19ALDH1A1
SCHEMBL25028024 0.77 ALDH1A1 (0.43) CYP1A2CYP2C19ALDH1A1PTGS1PDE7A
SCHEMBL7813124 0.74 IDO1 (0.55) IDO1TDO2CYP1A2CYP2C19ALDH1A1
SCHEMBL7814769 0.74 IDO1 (0.55) IDO1TDO2ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7808342 0.74 IDO1 (0.55) IDO1TDO2ALDH1A1PTGS1SMN1; SMN2
SCHEMBL7811413 0.73 IDO1 (0.50) IDO1TDO2NPC1RAB9A
SCHEMBL7811743 0.70 IDO1 (0.46) IDO1TDO2ALDH1A1BCL2ALOX5
SCHEMBL27506922 0.70 CYP1A2 (0.39) CYP1A2CYP2C19ALDH1A1PTGS1PDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 — — US disclosed
Send feedback